Earnings Summary

Vera Therapeutics Inc’s revenue jumped NaN% since last year same period to $0Mn in the Q4 2023. On a quarterly growth basis, Vera Therapeutics Inc has generated NaN% jump in its revenue since last 3-months.

Vera Therapeutics Inc’s net profit jumped 20.91% since last year same period to $-25.66Mn in the Q4 2023. On a quarterly growth basis, Vera Therapeutics Inc has generated -27.61% fall in its net profits since last 3-months.

Vera Therapeutics Inc’s net profit margin jumped NaN% since last year same period to -Inf% in the Q4 2023. On a quarterly growth basis, Vera Therapeutics Inc has generated NaN% jump in its net profit margins since last 3-months.

Vera Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.53 - a -3.92% fall from last quarter’s estimates.

Vera Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.53.

Vera Therapeutics Inc’s earning per share (EPS) jumped 49.15% since last year same period to -0.6 in the Q4 2023. This indicates that the Vera Therapeutics Inc has generated 49.15% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Vera Therapeutics Inc’s return on assets (ROA) stands at -0.42.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Vera Therapeutics Inc’s return on equity (ROE) stands at -1.08.